PRINTABLE CLINICIAN VIEW

Clinician orientation sheet

NM_018489.3:c.2550delT

Concise orientation only. Dates, normal findings, uncertainty, source boundaries, and longitudinal context remain in the complete profile.

Molecular result and profile context

Report transcript + cDNA
NM_018489.3:c.2550delT
Report protein consequence
p.Ala851Leufs*47
Zygosity
Heterozygous
Molecular consequence
Frameshift with premature termination
Laboratory classification
Pathogenic
Classification source
Family-reported formal result
Inheritance
De novo
Relevant additional finding
TRIO p.Ala2437Thr — paternally inherited and probably benign
Normalized MANE/map notation
NM_018489.3:c.2550delT · NP_060959.2:p.Ala851Leufs*47
Variant type
Frameshift
Sex
Female
Age group
Ages 26–30
Protein position
First altered residue · aa 851

Approved public summary

A woman in the 26–30 age group with a de novo pathogenic ASH1L frameshift variant. She had typical early milestones and clear early strengths, followed by school-age learning and memory difficulties, severe intellectual and executive-function support needs, progressive family-observed memory change, difficulty accessing words, and marked sleep-wake and fatigue episodes. She also has strong orientation and public-transport navigation skills, recognizes familiar people, enjoys friends and outings, and participates in structured social and occupational activities.